TODAY'S NEWS
In a retrospective cohort study reported by Win et...
In a large cohort study reported by Sharafeldin et...
The U.S. Food and Drug Administration (FDA)'s Onco...
As reported in The Lancet by Yelena Y. Janjigian, ...
To complement The ASCO Post’s continued comprehe...
More News From Today 
EDITORIALS & COMMENTARY
CAR T-cell therapy is rapidly emerging as a promising treatment for many hematologic malignancies...
Cases of chronic neutrophilic leukemia (CNL) are extremely rare and easily missed...
Diarrhea is often a presenting symptom in patients with neuroendocrine
tumors...
Advanced practitioners, including physician assistants and nurse practitioners, are medical professionals with...
Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy...
More Editorials & Commentary 
